Skip to main content

Table 5 Cost-Effectiveness ratios in costs (M€) /success (achieving a mortality reduction ≥ 40%)

From: The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?

 

Pandemic scenario

 

A

B

C

D

E

F

Individual measures

253.67

253.67

253.67

253.67

253.67

253.67

Border control

490.24

831.86

1755.03

1755.03

1755.03

2012.15

Community infection control measures

209409.26

209409.26

209409.26

209409.26

209409.26

209409.26

Reduction of secondary infections

30.99

30.99

30.99

30.99

30.99

30.99

Pneumococcal vaccination

543.49

543.49

543.49

543.49

543.49

543.49

Development of new ICU capacity

3.68

3.68

7.91

2893.38

2893.38

20237.91

Life support equipment

0.66

0.73

0.97

185.57

185.57

1295.45

Screening Interventions

1′061′547′989

1′061′547′989

1′061′547′989

1′061′547′989

1′061′547′989

1′061′547′989

Vaccination health professionals

629′540′680

629′540′680

629′540′680

629′540′680

629′540′680

629′540′680

Vaccination general population

1′409′493′454

1′409′493′45

1′409′493′45

1′409′493′45

1′409′493′45

1′409′493′45

  1. ICU: Intensive Care Units